SAFETY OF USTEKINUMAB IN IBD: FINAL POOLED LONG-TERM SAFETY ANALYSIS THROUGH 5 YEARS IN CD AND 4 YEARS IN UC

被引：0
|
作者：
Sands, Bruce E.
Feagan, Brian G.
Ott, Elyssa
Gasink, Christopher
Marano, Colleen W.
Miao, Ye
Sandborn, William J.
Danese, Silvio
Abreu, Maria T.
Ghosh, Subrata
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1743
引用
收藏
页码：S889 / S889
页数：1
相关论文
共 50 条
  • [21] Active Tuberculosis and Opportunistic Infections: Pooled Safety Analysis of Ustekinumab Through up to 5 Years Across All Approved Indications
    Loftus, Edward V.
    Long, Millie
    Ott, Elyssa
    Gasink, Christopher
    Baker, Thomas
    Goodwin, Bridget
    Miao, Ye
    Ghosh, Subrata
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S675 - S675
  • [22] Active tuberculosis and opportunistic infections: Pooled safety analysis of ustekinumab through up to 5 years across all approved indications
    Ghosh, S.
    Long, M.
    Ott, E.
    Gasink, C.
    Baker, T.
    Godwin, B.
    Miao, Y.
    Loftus, E.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 681 - 681
  • [23] LONG-TERM EFFICACY AND SAFETY OF USTEKINUMAB FOR CROHN'S DISEASE: RESULTS FROM IM-UNITI LONG-TERM EXTENSION THROUGH TWO YEARS
    Sandborn, William J.
    Rutgeerts, Paul
    Gasink, Christopher
    Jacobstein, Douglas
    Gao, Long-Long
    Johanns, Jewel
    Sands, Bruce E.
    Hanauer, Stephen B.
    Targan, Stephan R.
    Ghosh, Subrata
    de Villiers, Willem J.
    Colombel, Jean Frederic
    Feagan, Brian G.
    GASTROENTEROLOGY, 2017, 152 (05) : S585 - S585
  • [24] Long-term efficacy and safety of ustekinumab in patients with moderate to severe psoriasis through 5 years of follow-up: results from the PHOENIX 1 long-term extension
    Kimball, A. B.
    Papp, K. A.
    Wasfi, Y.
    Chan, D.
    Bissonnette, R.
    Sofen, H.
    Yeilding, N.
    Li, S.
    Szapary, P. O.
    Gordon, K. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 : 63 - 64
  • [25] EFFICACY OF USTEKINUMAB FOR ULCERATIVE COLITIS THROUGH 4 YEARS: FINAL CLINICAL AND ENDOSCOPY OUTCOMES FROM THE UNIFI LONG-TERM EXTENSION
    Peyrin-Biroulet, Laurent
    Afif, Waqqas
    Abreu, Maria T.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen J.
    Leong, Rupert
    Rowbotham, David S.
    Arasaradnam, Ramesh P.
    Sands, Bruce E.
    Marano, Colleen W.
    GASTROENTEROLOGY, 2023, 164 (06) : S1094 - S1094
  • [26] Efficacy of ustekinumab for ulcerative colitis through 4 years: Final clinical and endoscopy outcomes from the UNIFI long-term extension
    Danese, S.
    Afif, W.
    Abreu, M. T.
    Sandborn, W. J.
    Miao, Y.
    Zhang, H.
    Panaccione, R.
    Hisamatsu, T.
    Scherl, E. J.
    Leong, R.
    Rowbotham, D. S.
    Arasaradnam, R. P.
    Peyrin-Biroulet, L.
    Sands, B. E.
    Marano, C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 117 - 118
  • [27] Efficacy of ustekinumab for Ulcerative Colitis through 4 years: Final clinical and endoscopy outcomes from the UNIFI long-term extension
    Danese, S.
    Afif, W.
    Abreu, M.
    Sandborn, W.
    Miao, Y.
    Zhang, H.
    Panaccione, R.
    Hisamatsu, T.
    Scherl, E.
    Leong, R.
    Rowbotham, D.
    Arasaradnam, R.
    Peyrin-Biroulet, L.
    Sands, B.
    Marano, C.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I19 - I20
  • [28] Long term efficacy and safety of Ustekinumab for Crohn's disease: results from IM-UNITI long-term extension through 2 years
    Sandborn, W.
    Rutgeerts, P.
    Gasink, C.
    Jacobstein, D.
    Gao, L. -L.
    Johanns, J.
    Sands, B.
    Hanauer, S. B.
    Targan, S.
    Ghosh, S.
    de Villiers, W. J. S.
    Colombel, J. -F.
    Feagan, B. G.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S6 - S6
  • [29] Long term efficacy and safety of ustekinumab in patients with moderate to severe psoriasis through 5 years of follow-up: results from the PHOENIX 1 long-term extension
    Papp, K.
    Kimball, A.
    Wasfi, Y.
    Chan, D.
    Bissonnette, R.
    Sofen, H.
    Yeilding, N.
    Li, S.
    Szapary, P.
    Gordon, K.
    JOURNAL OF DERMATOLOGY, 2012, 39 : 239 - 240
  • [30] LONG TERM EFFICACY AND SAFETY OF USTEKINUMAB FOR CROHN'S DISEASE: RESULTS FROM IM-UNITI LONG-TERM EXTENSION THROUGH 2 YEARS
    Sandborn, W. J.
    Rutgeerts, P.
    Gasink, C.
    Jacobstein, D.
    Gao, L.
    Johanns, J.
    Sands, B.
    Hanauer, S.
    Targan, S.
    Ghosh, S.
    de Villiers, W. J. S.
    Colombel, J. F.
    Feagan, B. G.
    GUT, 2017, 66 : A22 - A22
12345